Three years ago, the cigarette giant acquired Vectura, a British pharmaceutical firm that makes asthma inhalers, raising ...

New reports reveal the most commonly prescribed inhaler in the U.S. may actually be contributing to climate change.

Tectonic recently announced the U.S. Food and Drug Administration cleared its Investigational New Drug application for TX45. Screening for the Phase 2 APEX clinical trial has been initiated and ...

Inhalers, nebulizers, and airway clearance devices are key to columnist Caroline Gainer's COPD management strategy.

About This EventVerona Pharma (Nasdaq: VRNA), a biopharmaceutical company focused on respiratory diseases, visits the Nasdaq MarketSite in Times Square, to celebrate the approval of OhtuvayreTM ...

Dr. Scott Cyrus offers expert insights into asthma, including common symptoms, effective treatments, and management strategies to improve the quality of life for those affected by the condition.

Adding GSK’s mepolizumab to standard inhaled treatment for COPD reduces the frequency of exacerbations in patients with type ...

Enrollment required an acute exacerbation of COPD, an arterial pH level of less than 7.35 ... The mean forced expiratory volume in the first second of expiration (FEV1) was 36% predicted, 86% of ...

Katrina Berry was 24 years old when she first started experiencing symptoms of pulmonary arterial hypertension (PAH), a ...

The modern debate over ICSs in COPD has the catnip required to produce an academic catfight. It pits "statements" against ...